468
Views
45
CrossRef citations to date
0
Altmetric
Reviews

Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status

, &
Pages 23-37 | Published online: 20 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Boonchai Boonyawat, Chalinee Monsereenusorn, Apichat Photia, Nawachai Lertvivatpong, Varissara Kaewchaivijit, Punyanuch Jindatanmanusan & Piya Rujkijyanont. (2021) ITPA:c.94C>A and NUDT15:c.415C>T Polymorphisms and Their Relation to Mercaptopurine-Related Myelotoxicity in Childhood Leukemia in Thailand. The Application of Clinical Genetics 14, pages 341-351.
Read now
Stéphanie Dulucq, Caroline Laverdière, Daniel Sinnett & Maja Krajinovic. (2014) Pharmacogenetic considerations for acute lymphoblastic leukemia therapies. Expert Opinion on Drug Metabolism & Toxicology 10:5, pages 699-719.
Read now
Nathan D Meeker, Jun J Yang & Joshua D Schiffman. (2010) Pharmacogenomics of pediatric acute lymphoblastic leukemia. Expert Opinion on Pharmacotherapy 11:10, pages 1621-1632.
Read now

Articles from other publishers (42)

Hong-Li Guo, Yue-Tao Zhao, Wei-Jun Wang, Na Dong, Ya-Hui Hu, Yuan-Yuan Zhang, Feng Chen, Li Zhou & Tao Li. (2022) Optimizing thiopurine therapy in children with acute lymphoblastic leukemia: A promising “MINT” sequencing strategy and therapeutic “DNA-TG” monitoring. Frontiers in Pharmacology 13.
Crossref
Yeonhong Lee, Eun Jeong Jang, Ha-Young Yoon, Jeong Yee & Hye-Sun Gwak. (2022) Effect of ITPA Polymorphism on Adverse Drug Reactions of 6-Mercaptopurine in Pediatric Patients with Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis. Pharmaceuticals 15:4, pages 416.
Crossref
Ankita Singh, Harikrishnan Gangadharan, Vikas Gupta, Pradeepta S. Patro, Ramnath Misra & Amita Aggarwal. (2021) Polymorphism of genes involved in methotrexate pathway: Predictors of response to methotrexate therapy in Indian rheumatoid arthritis patients. International Journal of Rheumatic Diseases 24:5, pages 654-662.
Crossref
Miriam Saiz‐Rodríguez, Dolores Ochoa, Carmen Belmonte, Manuel Román, Cristina Martínez‐Ingelmo, Lucía Ortega‐Ruíz, Carmen Sarmiento‐Iglesias, Coral Herrador & Francisco Abad‐Santos. (2018) Influence of thiopurine S‐methyltransferase polymorphisms in mercaptopurine pharmacokinetics in healthy volunteers. Basic & Clinical Pharmacology & Toxicology 124:4, pages 449-455.
Crossref
Sarah Cargnin, Armando A. Genazzani, Pier Luigi Canonico & Salvatore Terrazzino. (2018) Diagnostic accuracy of NUDT15 gene variants for thiopurine-induced leukopenia: a systematic review and meta-analysis. Pharmacological Research 135, pages 102-111.
Crossref
Nikolaos Tsesmetzis, Cynthia Paulin, Sean Rudd & Nikolas Herold. (2018) Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism. Cancers 10:7, pages 240.
Crossref
Tina Gerbek, Maria Ebbesen, Jacob Nersting, Thomas L. Frandsen, Malin Lindqvist Appell & Kjeld Schmiegelow. (2018) Role of TPMT and ITPA variants in mercaptopurine disposition. Cancer Chemotherapy and Pharmacology 81:3, pages 579-586.
Crossref
Yoichi Kakuta, Yoshitaka Kinouchi & Tooru Shimosegawa. (2017) Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping. Journal of Gastroenterology 53:2, pages 172-180.
Crossref
Antony Citterio-Quentin, Mustapha Moulsma, Marie-Paule Gustin & Roselyne Boulieu. (2017) ITPA Activity in Adults and Children Treated With or Without Azathioprine: Relationship Between TPMT Activity, Thiopurine Metabolites, and Co-medications. Therapeutic Drug Monitoring 39:5, pages 483-491.
Crossref
R Franca, P Rebora, N Bertorello, F Fagioli, V Conter, A Biondi, A Colombini, C Micalizzi, M Zecca, R Parasole, F Petruzziello, G Basso, M C Putti, F Locatelli, P d'Adamo, M G Valsecchi, G Decorti & M Rabusin. (2015) Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol. The Pharmacogenomics Journal 17:1, pages 4-10.
Crossref
Marzena Skrzypczak-Zielinska, Pawel Borun, Anna Bartkowiak-Kaczmarek, Oliwia Zakerska-Banaszak, Michal Walczak, Agnieszka Dobrowolska, Mateusz Kurzawski, Malgorzata Waszak, Daniel Lipinski, Andrzej Plawski & Ryszard Slomski. (2016) A Simple Method for TPMT and ITPA Genotyping Using Multiplex HRMA for Patients Treated with Thiopurine Drugs. Molecular Diagnosis & Therapy 20:5, pages 493-499.
Crossref
Mehmet Coskun, Casper Steenholdt, Nanne K. de Boer & Ole Haagen Nielsen. (2015) Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease. Clinical Pharmacokinetics 55:3, pages 257-274.
Crossref
T. Adam de Beaumais, A. Baruchel & E. Jacqz-Aigrain. (2015) Approches méthodologiques en pharmacogénétique : le modèle des leucémies aiguës lymphoblastiques de l’enfant. Revue d'Oncologie Hématologie Pédiatrique 3:4, pages 215-220.
Crossref
Fatemeh Azimi, Yousef Mortazavi, Samin Alavi, Mitra Khalili & Ali Ramazani. (2015) Frequency of ITPA gene polymorphisms in Iranian patients with acute lymphoblastic leukemia and prediction of its myelosuppressive effects. Leukemia Research 39:10, pages 1048-1054.
Crossref
Ryoko Suzuki, Hiroko Fukushima, Emiko Noguchi, Masahiro Tsuchida, Nobutaka Kiyokawa, Kazutoshi Koike, Enbo Ma, Hideto Takahashi, Chie Kobayashi, Ryoko Nakajima-Yamaguchi, Aiko Sakai, Makoto Saito, Atsushi Iwabuchi, Keisuke Kato, Tomohei Nakao, Ai Yoshimi, Ryo Sumazaki & Takashi Fukushima. (2015) Influence of SLCO1B1 polymorphism on maintenance therapy for childhood leukemia . Pediatrics International 57:4, pages 572-577.
Crossref
Lin Mei, Evelena P. Ontiveros, Elizabeth A. Griffiths, James E. Thompson, Eunice S. Wang & Meir Wetzler. (2015) Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy. Blood Reviews 29:4, pages 243-249.
Crossref
Phuong Thu Vu Hoang, Jérôme Ambroise, Anne-France Dekairelle, Jean-François Durant, Valentina Butoescu, Vu Luan Dang Chi, Nghia Huynh, Tan Binh Nguyen, Annie Robert, Christiane Vermylen & Jean-Luc Gala. (2015) Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?. British Journal of Clinical Pharmacology 79:3, pages 429-440.
Crossref
Mauricio J Farfan, Carolina Salas, Cristina Canales, Felipe Silva, Milena Villarroel, Katherine Kopp, Juan P Torres, María E Santolaya & Jorge Morales. (2014) Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia. BMC Cancer 14:1.
Crossref
Ping LiQuan ChenYa-Di WangMin-Wen Ha. (2014) Effects of MTHFR Genetic Polymorphisms on Toxicity and Clinical Response of Irinotecan-Based Chemotherapy in Patients with Colorectal Cancer . Genetic Testing and Molecular Biomarkers 18:5, pages 313-322.
Crossref
Gabriele Stocco, Eva Cuzzoni, Sara De Iudicibus, Raffaella Franca, Diego Favretto, Noelia Malusà, Margherita Londero, Gabriele Cont, Fiora Bartoli, Stefano Martelossi, Alessandro Ventura & Giuliana Decorti. (2014) Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 48:1, pages 43-51.
Crossref
Nicholas C. Dracopoli & Katie Streicher. 2014. Genomic Biomarkers for Pharmaceutical Development. Genomic Biomarkers for Pharmaceutical Development 23 49 .
Peter D. Simone, Youri I. Pavlov & Gloria E.O. Borgstahl. (2013) ITPA (inosine triphosphate pyrophosphatase): From surveillance of nucleotide pools to human disease and pharmacogenetics. Mutation Research/Reviews in Mutation Research 753:2, pages 131-146.
Crossref
Hazhar Karim, Aram Ghalali, Pierre Lafolie, Sigurd Vitols & Alan K. Fotoohi. (2013) Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells. Biochemical and Biophysical Research Communications 437:2, pages 280-286.
Crossref
Adele Corrigan, Monica Arenas-Hernandez, Paul Blaker, Jeremy Sanderson & Anthony Marinaki. (2012) Let’s get personal: predicting thiopurine and fluoropyrimidine toxicity. Personalized Medicine 9:8, pages 859-870.
Crossref
Paul Andrew BlakerMonica Arenas-Hernandez, Anthony Marin Marinaki & Jeremy David Sanderson. (2012) The pharmacogenetic basis of individual variation in thiopurine metabolism. Personalized Medicine 9:7, pages 707-725.
Crossref
Steven W. Paugh, Mary V. Relling & William E. Evans. 2013. Childhood Leukemias. Childhood Leukemias 309 331 .
Paul S. Gaynon, Toska J. Zomorodian & Donald Pinkel. 2013. Childhood Leukemias. Childhood Leukemias 1 20 .
Daniel CronaFederico Innocenti. (2012) Can knowledge of germline markers of toxicity optimize dosing and efficacy of cancer therapy?. Biomarkers in Medicine 6:3, pages 349-362.
Crossref
Navin Pinto, Susan L. Cohn & M. Eileen Dolan. (2012) Using Germline Genomics to Individualize Pediatric Cancer Treatments. Clinical Cancer Research 18:10, pages 2791-2800.
Crossref
Yoichi Tanaka, Atsushi Manabe, Hisaya Nakadate, Kensuke Kondoh, Kozue Nakamura, Katsuyoshi Koh, Tomoyuki Utano, Akira Kikuchi & Takako Komiyama. (2012) The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children. Leukemia Research 36:5, pages 560-564.
Crossref
Bo PangJose L. McFalineNicholas E. Burgis, Min DongKoli Taghizadeh, Matthew R. SullivanC. Eric ElmquistRichard P. Cunningham & Peter C. Dedon. (2012) Defects in purine nucleotide metabolism lead to substantial incorporation of xanthine and hypoxanthine into DNA and RNA. Proceedings of the National Academy of Sciences 109:7, pages 2319-2324.
Crossref
Ute Hofmann, Georg Heinkele, Sieglinde Angelberger, Elke Schaeffeler, Cornelia Lichtenberger, Simon Jaeger, Walter Reinisch & Matthias Schwab. (2012) Simultaneous Quantification of Eleven Thiopurine Nucleotides by Liquid Chromatography-Tandem Mass Spectrometry. Analytical Chemistry 84:3, pages 1294-1301.
Crossref
L. Chouchana, C. Narjoz, P. Beaune, M.‐A. Loriot & X. Roblin. (2011) Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 35:1, pages 15-36.
Crossref
S W Paugh, G Stocco, J R McCorkle, B Diouf, K R Crews & W E Evans. (2011) Cancer Pharmacogenomics. Clinical Pharmacology & Therapeutics 90:3, pages 461-466.
Crossref
Hans-Georg Eichler, Eric Abadie, Alasdair Breckenridge, Bruno Flamion, Lars L. Gustafsson, Hubert Leufkens, Malcolm Rowland, Christian K. Schneider & Brigitte Bloechl-Daum. (2011) Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response. Nature Reviews Drug Discovery 10:7, pages 495-506.
Crossref
Hazhar Karim, Jamileh Hashemi, Catharina Larsson, Ali Moshfegh, Alan K. Fotoohi & Freidoun Albertioni. (2011) The pattern of gene expression and gene dose profiles of 6-Mercaptopurine- and 6-Thioguanine-resistant human leukemia cells. Biochemical and Biophysical Research Communications 411:1, pages 156-161.
Crossref
Valery Elie, Tiphaine de Beaumais, May Fakhoury & Evelyne Jacqz-Aigrain. (2011) Pharmacogenetics and individualized therapy in children: immunosuppressants, antidepressants, anticancer and anti-inflammatory drugs. Pharmacogenomics 12:6, pages 827-843.
Crossref
S. Ngo, G. Sauvetre, O. Vittecoq, H. Lévesque & I. Marie. (2011) Aplasie médullaire induite par l’azathioprine : intérêt de la recherche systématique d’une mutation du gène de la thiopurine S-méthyltransférase ?. La Revue de Médecine Interne 32:6, pages 373-376.
Crossref
Seyhan Yağar, Soner Yavaş & Bensu Karahalil. (2010) The role of the ADRA2A C1291G genetic polymorphism in response to dexmedetomidine on patients undergoing coronary artery surgery. Molecular Biology Reports 38:5, pages 3383-3389.
Crossref
Tiphaine Adam de Beaumais, May Fakhoury, Yves Medard, Said Azougagh, Daolun Zhang, Karima Yakouben & Evelyne Jacqz-Aigrain. (2011) Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy. British Journal of Clinical Pharmacology 71:4, pages 575-584.
Crossref
Cynthia A. Prows. (2011) Infusion of Pharmacogenetics Into Cancer Care. Seminars in Oncology Nursing 27:1, pages 45-53.
Crossref
Steven W Paugh, Gabriele Stocco & William E Evans. (2010) Pharmacogenomics in pediatric leukemia. Current Opinion in Pediatrics 22:6, pages 703-710.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.